Concepedia

John R. Sims

JR

Statistics

Publications

83

Citations

11.1K

H-Index

40

Active since

1953

Affiliations

Eli Lilly (United States)(Current)

Massachusetts General Hospital

Harvard University

Brigham and Women's Hospital

Brown University

John R. Sims is an author at Eli Lilly (United States) specializing in medicine, neurology, and neuroscience.

ORCID

Top concepts

Publications per year

1953–2025

83

Publications

83

Donanemab in Early Symptomatic Alzheimer Disease

John R. Sims, Jennifer A. Zimmer, Cynthia Evans et al. · JAMA · 2023 · 2.2K citations · Full text

Donanemab in Early Alzheimer’s Disease

Mark A. Mintun, Albert Lo, Cynthia Evans et al. · New England Journal of Medicine · 2021 · 1.5K citations · Full text

Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration

Elisabeth H. Thijssen, Renaud La Joie, Amy Wolf et al. · Nature Medicine · 2020 · 767 citations · Full text

, , +13

Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease

Shorena Janelidze, Erik Stomrud, Ruben Smith et al. · Nature Communications · 2020 · 437 citations · Full text

ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes

John R. Sims, Leila Rezai Gharai, Pamela W. Schaefer et al. · Neurology · 2009 · 409 citations · Full text

1–5 of 83